A few days ago, the strategic cooperation unit of Shanghai International Medical Center, Yiji Medical FristBe, and Japan have used artificial intelligence to quantitatively grasp and predict the time and possibility of onset of cognitive impairment and major depression by studying MRI (T1-weighted image) of subjects. The signing ceremony is completed online to make it possible to predict and intervene in the clinical and research work of cognitive impairment and major depression.
It is reported that the two parties will adhere to the principle of "resource sharing, resource complementation, and health delivery", using the latest Japanese technology, focusing on the Chinese elderly care industry, in the "judgment of dementia (commonly known as Alzheimer's disease, hereinafter specifically referred to as Alzheimer's disease). In-depth cooperation in the field of "the current status and development trend of the disease", hoping to contribute to the creation of a healthy aging community in China through early detection and early intervention of the disease.
According to the "Research Report on the Family Survival Status of Alzheimer's Disease Patients in China in 2019" released by the China Geriatric Healthcare Association, as of 2019, China has 10 million patients with Alzheimer's disease, which is the largest number in the world. One person will be added every second, and it is estimated that by 2050, this group will exceed 30 million people. This disease has also become the fourth killer that threatens the health of the elderly after heart, cerebrovascular diseases, and cancer. As a degenerative disease of the nervous system with an insidious onset, patients with Alzheimer’s disease do not know new friends from the beginning, gradually do not know old friends, and finally do not know themselves. It is currently one of the top ten causes of death from chronic diseases in humans. In addition, patients with Alzheimer's disease will live without self-esteem in the last 10 to 20 years, making their family members miserable and embarrassed. As the patient’s family described it: one person is demented, and the whole family is out of balance.
Shanghai International Medical Center and Yiji Medical FristBe and Japan’s Alisa Company use advanced technology to conduct brain imaging analysis, build a "diagnostic support, predictive prevention" system for cognitive impairment diseases, and provide new technology, The new ideas provide us with reference and thinking in dealing with China's entry into an aging society.
At the same time, the collaboration technology between FristBe and Elisa in Yiji Medical can also be applied to the screening of major depression. In 2019, Professor Huang Yueqin from Peking University Sixth Hospital published a research article in The Lancet Psychiatry In China, the 12-month prevalence rate of depression patients in China is 3.6%, while the lifetime prevalence rate reaches 6.9%. Based on this estimate, there are approximately 95 million depression patients in my country. This data also means that out of every 15 people, there is a depression patient, they exist around us.
To predict the detection and development of dementia, or for patients and their families who need to be screened for major depression, they can be first diagnosed by the International Medical Department of the Shanghai International Medical Center specially appointed by Yiji Medical FristBe, and perform thin-layer brain MRI detection. , Through the diagnosis and evaluation of experts, through cloud transmission to realize data sharing with Japan Elisa, and perform artificial intelligence analysis, you can judge the subject’s current brain health and the future risk of dementia or severe disease. The time axis is calculated, and finally interpreted by experts from the Shanghai International Medical Center and corresponding treatment and intervention are adopted.
It is believed that in the near future, the middle-aged and elderly people in our country can realize the predictability of dementia, and the people under pressure can also realize the screening of major depression, and then carry out scientific intervention earlier.
No comments:
Post a Comment